METiS TechBio (7666.HK), a tech-bio company focused on AI-powered nanodelivery innovation, today successfully listed on the ...

Researchers have identified a pathway that triggers an immune response in cells with defective DNA repair. In particular, the ...

Ultimately, Dr. Minn notes, success in immuno-oncology will be measured in multiple ways: Scientifically, by the depth of ...

Oligonucleotide-based therapeutics represent a frontier in immunology, regenerative medicine, and oncology, offering unparalleled precision in modulating ...

Cancer immunotherapy is built on a simple but powerful idea: the immune system can recognize and destroy cancer cells if it ...

Members include Nobel laureate James P. Allison, Padmanee Sharma, Taha Merghoub, and Kingston Mills, who are all globally renowned experts in cancer immunotherapy and translational cancer ...

From studying microRNAs in embryonic stem cells to exploring exosomes in anti-tumor immunity, Blelloch illustrates how ...

AUSTIN (KXAN) — An experimental chemo therapy drug may change how we fight cancer by treating it like a virus. Discovered by researchers at The University of Texas at Austin and The University of ...

A newly identified self-regulating molecule may explain why some cancer immunotherapies fall short. Early findings hint that disabling this pathway could unlock stronger, longer-lasting antitumor ...

The finding suggests other chemo drugs, too, may be making cancer cells cause a surprising immune-system reaction. Microscope image of colon cancer cells. The mouse model used in this study mimics ...

The nervous system is increasingly recognized as a dynamic and regulatory component of the tumor microenvironment playing critical roles in cancer initiation, progression, metastasis, and resistance ...